Search

Displaying results 1811 - 1820 of 10000 in total

Drug
Tebentafusp
go.drugbank.com/drugs/DB15283
ApprovedInvestigational
of action. … Even after surgical ablation or removal of the ocular tumour, almost 50% of patients with uveal melanoma develop metastatic disease.
Drug
Cholestyramine
go.drugbank.com/drugs/DB01432
ApprovedInvestigational
Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins.
Categories: Compounds used in a research, industrial, or household settingProducts: COLESTIRAMINA 4 G., COLESTYRAMIN HEXAL 4G
Drug
Hetacillin
go.drugbank.com/drugs/DB00739
ApprovedVet approvedWithdrawn
The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. … The bactericidal activity of Hetacillin results from the inhibition of cell wall synthesis and is mediated through Hetacillin binding to penicillin binding proteins (PBPs).
Categories: combinations of penicillins
Drug
Malathion
go.drugbank.com/drugs/DB00772
Approved
Malathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice.
Categories: Compounds used in a research, industrial, or household settingSynonyms: O,O-dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl), O,O-dimethyl S-1,2-di(ethoxycarbamyl)ethyl
Drug
Mephentermine
go.drugbank.com/drugs/DB01365
ApprovedWithdrawn
Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. … A sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Drug
Olutasidenib
go.drugbank.com/drugs/DB16267
ApprovedInvestigational
[A254726,L44256] Other IDH1 inhibitors, such as [ivosidenib], have also been approved for the treatment of relapsed or refractory AML. … [L44256,L44261] It is indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) in patients with a susceptible IDH1 mutation as determined by an FDA-approved test.
Drug
Veligrotug
go.drugbank.com/drugs/DB18976
Approved
[L63929] The FDA approved veligrotug-vvze on June 26, 2026, for the treatment of thyroid eye disease regardless of disease activity or duration.[L63798,L63929] … [L63798] Thyroid eye disease has historically been managed differently depending on whether it is caught in the active inflammatory phase or has become chronic - Viridian describes veligrotug-vvze as the
Drug
Fenpropidin
go.drugbank.com/drugs/DB12728
ApprovedWithdrawn
Fenpropidin has been investigated for the treatment of Hernia.
Categories: Compounds used in a research, industrial, or household setting
Drug
Bromocriptine
go.drugbank.com/drugs/DB01200
ApprovedInvestigationalWithdrawn
Bromocriptine is also indicated for the management of signs and symptoms of Parkinsonian Syndrome, as well as the treatment of acromegaly. … In 1995, the FDA withdrew the approval of bromocriptine mesylate for the prevention of physiological lactation after finding that bromocriptine was not shown to be safe for use.
Categories: Heterocyclic Compounds with 4 or More RingsProducts: Nu-bromocriptine, PARLODEL 2.5 MG
Drug
Elivaldogene autotemcel
go.drugbank.com/drugs/DB16746
Approved
Without sufficient levels of functional ALDP, VLCFAs accumulate in the body leading to inflammation and destruction of myelin, which is an insulating layer and essential component of nerves. … It is used to provide functional copies of human adrenoleukodystrophy protein (ALDP) in patients with adrenoleukodystrophy,[L39491] an X-linked genetic disorder characterized by missing or non-functional